Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Sitagliptin + Metformin film-coated tablets vs Janumet under fed conditions in healthy Thai volunteers
TCTR20211015002Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of sitagliptin + metformin, sitagliptin and metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Bio-innova. Planned start Jan 2022; status: not yet recruiting.
02
Drugs
sitagliptin + metforminsitagliptinmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20211015002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211015002.